Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Meningioma Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Meningioma Drugmarket, defines the market attractiveness level of Meningioma Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Meningioma Drug industry, describes the types of Meningioma Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Meningioma Drug market and the development prospects and opportunities of Meningioma Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Meningioma Drug market in Chapter 13.
By Player:
Progenics Pharmaceuticals Inc
Ono Pharmaceutical Co Ltd
Merck & Co Inc
Merck KGaA
Pharma Mar SA
Genentech Inc
Boehringer Ingelheim GmbH
Eli Lilly and Co
Novartis AG
AstraZeneca Plc
GlaxoSmithKline Plc
Arno Therapeutics Inc
By Type:
Abemaciclib
Afatinib Dimaleate
AR-42
Avelumab
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Meningioma Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Meningioma Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Meningioma Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Meningioma Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Meningioma Drug Market Analysis and Outlook to 2022
-
7.1 Global Meningioma Drug Consumption (2017-2022)
-
7.2 United States Meningioma Drug Consumption (2017-2022)
-
7.3 Europe Meningioma Drug Consumption (2017-2022)
-
7.4 China Meningioma Drug Consumption (2017-2022)
-
7.5 Japan Meningioma Drug Consumption (2017-2022)
-
7.6 India Meningioma Drug Consumption (2017-2022)
-
7.7 South Korea Meningioma Drug Consumption (2017-2022)
8 Region and Country-wise Meningioma Drug Market Analysis and Outlook to 2028
-
8.1 Global Meningioma Drug Consumption Forecast (2022-2028)
-
8.2 United States Meningioma Drug Consumption Forecast (2022-2028)
-
8.3 Europe Meningioma Drug Consumption Forecast (2022-2028)
-
8.4 China Meningioma Drug Consumption Forecast (2022-2028)
-
8.5 Japan Meningioma Drug Consumption Forecast (2022-2028)
-
8.6 India Meningioma Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Meningioma Drug Consumption Forecast (2022-2028)
9 Global Meningioma Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Meningioma Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Abemaciclib Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Afatinib Dimaleate Consumption and Growth Rate (2017-2022)
-
9.1.3 Global AR-42 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Avelumab Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Meningioma Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Meningioma Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Meningioma Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Abemaciclib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Afatinib Dimaleate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global AR-42 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Avelumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Meningioma Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Meningioma Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Meningioma Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Meningioma Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Meningioma Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Meningioma Drug Market Competitive Analysis
-
14.1 Progenics Pharmaceuticals Inc
-
14.1.1 Progenics Pharmaceuticals Inc Company Details
-
14.1.2 Progenics Pharmaceuticals Inc Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Progenics Pharmaceuticals Inc Meningioma Drug Product and Service
-
14.2 Ono Pharmaceutical Co Ltd
-
14.2.1 Ono Pharmaceutical Co Ltd Company Details
-
14.2.2 Ono Pharmaceutical Co Ltd Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Ono Pharmaceutical Co Ltd Meningioma Drug Product and Service
-
14.3 Merck & Co Inc
-
14.3.1 Merck & Co Inc Company Details
-
14.3.2 Merck & Co Inc Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck & Co Inc Meningioma Drug Product and Service
-
14.4 Merck KGaA
-
14.4.1 Merck KGaA Company Details
-
14.4.2 Merck KGaA Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck KGaA Meningioma Drug Product and Service
-
14.5 Pharma Mar SA
-
14.5.1 Pharma Mar SA Company Details
-
14.5.2 Pharma Mar SA Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pharma Mar SA Meningioma Drug Product and Service
-
14.6 Genentech Inc
-
14.6.1 Genentech Inc Company Details
-
14.6.2 Genentech Inc Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Genentech Inc Meningioma Drug Product and Service
-
14.7 Boehringer Ingelheim GmbH
-
14.7.1 Boehringer Ingelheim GmbH Company Details
-
14.7.2 Boehringer Ingelheim GmbH Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Boehringer Ingelheim GmbH Meningioma Drug Product and Service
-
14.8 Eli Lilly and Co
-
14.8.1 Eli Lilly and Co Company Details
-
14.8.2 Eli Lilly and Co Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eli Lilly and Co Meningioma Drug Product and Service
-
14.9 Novartis AG
-
14.9.1 Novartis AG Company Details
-
14.9.2 Novartis AG Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis AG Meningioma Drug Product and Service
-
14.10 AstraZeneca Plc
-
14.10.1 AstraZeneca Plc Company Details
-
14.10.2 AstraZeneca Plc Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 AstraZeneca Plc Meningioma Drug Product and Service
-
14.11 GlaxoSmithKline Plc
-
14.11.1 GlaxoSmithKline Plc Company Details
-
14.11.2 GlaxoSmithKline Plc Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 GlaxoSmithKline Plc Meningioma Drug Product and Service
-
14.12 Arno Therapeutics Inc
-
14.12.1 Arno Therapeutics Inc Company Details
-
14.12.2 Arno Therapeutics Inc Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Arno Therapeutics Inc Meningioma Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Meningioma Drug
-
Figure Meningioma Drug Picture
-
Table Global Meningioma Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Meningioma Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Meningioma Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Meningioma Drug Consumption by Country (2017-2022)
-
Figure United States Meningioma Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Meningioma Drug Consumption and Growth Rate (2017-2022)
-
Figure China Meningioma Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Meningioma Drug Consumption and Growth Rate (2017-2022)
-
Figure India Meningioma Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Meningioma Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Meningioma Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Meningioma Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Meningioma Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Meningioma Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Meningioma Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Meningioma Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Meningioma Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Abemaciclib Consumption and Growth Rate (2017-2022)
-
Figure Global Afatinib Dimaleate Consumption and Growth Rate (2017-2022)
-
Figure Global AR-42 Consumption and Growth Rate (2017-2022)
-
Figure Global Avelumab Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Abemaciclib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Afatinib Dimaleate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AR-42 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Avelumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Meningioma Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Meningioma Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Progenics Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Progenics Pharmaceuticals Inc Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Progenics Pharmaceuticals Inc Meningioma Drug Product and Service
-
Table Ono Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Ono Pharmaceutical Co Ltd Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ono Pharmaceutical Co Ltd Meningioma Drug Product and Service
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Meningioma Drug Product and Service
-
Table Merck KGaA (Foundation Year, Company Profile and etc.)
-
Table Merck KGaA Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck KGaA Meningioma Drug Product and Service
-
Table Pharma Mar SA (Foundation Year, Company Profile and etc.)
-
Table Pharma Mar SA Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharma Mar SA Meningioma Drug Product and Service
-
Table Genentech Inc (Foundation Year, Company Profile and etc.)
-
Table Genentech Inc Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Inc Meningioma Drug Product and Service
-
Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim GmbH Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Meningioma Drug Product and Service
-
Table Eli Lilly and Co (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Co Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Co Meningioma Drug Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Meningioma Drug Product and Service
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc Meningioma Drug Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Meningioma Drug Product and Service
-
Table Arno Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Arno Therapeutics Inc Meningioma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arno Therapeutics Inc Meningioma Drug Product and Service
-
